Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

How Can Health Care Professionals Communicate Effectively with Adolescent and Young Adults Who Have Completed Cancer Treatment? A Systematic Review.

Smith LAM, Critoph DJ, Hatcher HM.

J Adolesc Young Adult Oncol. 2020 Jan 14. doi: 10.1089/jayao.2019.0133. [Epub ahead of print]

PMID:
31934804
2.

Regulatory interfaces surrounding the growing field of additive manufacturing of medical devices and biologic products.

Adamo JE, Grayson WL, Hatcher H, Brown JS, Thomas A, Hollister S, Steele SJ.

J Clin Transl Sci. 2018 Oct;2(5):301-304. doi: 10.1017/cts.2018.331. Epub 2018 Nov 29.

3.

Cardiotoxicity with trabectedin in the treatment of advanced soft tissue sarcoma.

Doherty GJ, Davidson D, Wong HH, Hatcher HM.

Anticancer Drugs. 2019 Jan;30(1):110-115. doi: 10.1097/CAD.0000000000000693.

PMID:
30540596
4.

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

Hensley ML, Enserro D, Hatcher H, Ottevanger PB, Krarup-Hansen A, Blay JY, Fisher C, Moxley KM, Lele SB, Lea JS, Tewari KS, Thaker PH, Zivanovic O, O'Malley DM, Robison K, Miller DS.

J Clin Oncol. 2018 Oct 5:JCO1800454. doi: 10.1200/JCO.18.00454. [Epub ahead of print]

5.

Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly Managed.

Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Barclay M, Brimicombe J, Thiemann P, McCabe MG, Campsey R, Hooker L, Moss W, Robson J, Barclay S.

J Adolesc Young Adult Oncol. 2017 Sep;6(3):489-493. doi: 10.1089/jayao.2017.0037. Epub 2017 Jul 17.

6.

Borderline Sarcomas and Smooth Muscle Tumours of Uncertain Malignant Potential.

Prewett S, Horan G, Hatcher H, Ajithkumar T.

Clin Oncol (R Coll Radiol). 2017 Aug;29(8):528-537. doi: 10.1016/j.clon.2017.05.005. Epub 2017 Jun 5. Review.

PMID:
28595873
7.

Multidisciplinary Management of Sarcomas - Where Are We Now?

Ajithkumar TV, Hatcher H.

Clin Oncol (R Coll Radiol). 2017 Aug;29(8):467-470. doi: 10.1016/j.clon.2017.05.004. Epub 2017 Jun 3. No abstract available.

PMID:
28583345
8.

Systemic Treatments in Soft Tissue Sarcomas.

Hatcher H, Benson C, Ajithkumar T.

Clin Oncol (R Coll Radiol). 2017 Aug;29(8):507-515. doi: 10.1016/j.clon.2017.05.002. Epub 2017 May 26. Review.

PMID:
28552518
9.

Pazopanib, a promising option for the treatment of aggressive fibromatosis.

Szucs Z, Messiou C, Wong HH, Hatcher H, Miah A, Zaidi S, van der Graaf WT, Judson I, Jones RL, Benson C.

Anticancer Drugs. 2017 Apr;28(4):421-426. doi: 10.1097/CAD.0000000000000474.

10.

Anticancer chemotherapy in teenagers and young adults: managing long term side effects.

Ahmad SS, Reinius MA, Hatcher HM, Ajithkumar TV.

BMJ. 2016 Sep 7;354:i4567. doi: 10.1136/bmj.i4567. Review. No abstract available.

11.

A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?

Szucs Z, Davidson D, Wong HH, Horan G, Bearcroft PW, Grant I, Grimer R, Hopper MA, Hatcher H, Earl H.

Sarcoma. 2016;2016:6032606. doi: 10.1155/2016/6032606. Epub 2016 Jun 2.

12.

Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?

Gounaris I, Iddawela M, Parkinson C, Pratt J, Hatcher H, Basu B, Tan LT, Brenton JD, Earl HM.

Anticancer Drugs. 2016 Mar;27(3):239-44. doi: 10.1097/CAD.0000000000000320.

PMID:
26575000
13.

Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury.

Hatcher HC, Tesfay L, Torti SV, Torti FM.

PLoS One. 2015 Sep 17;10(9):e0138505. doi: 10.1371/journal.pone.0138505. eCollection 2015.

14.

F10 Inhibits Growth of PC3 Xenografts and Enhances the Effects of Radiation Therapy.

Gmeiner WH, Willingham MC, Bourland JD, Hatcher HC, Smith TL, D'Agostino RB Jr, Blackstock W.

J Clin Oncol Res. 2014 Jul-Aug;2(4). pii: 1028.

15.

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.

Sayal K, Gounaris I, Basu B, Freeman S, Moyle P, Hosking K, Iddawela M, Jimenez-Linan M, Abraham J, Brenton J, Hatcher H, Earl H, Parkinson C.

Int J Gynecol Cancer. 2015 Jul;25(6):977-84. doi: 10.1097/IGC.0000000000000448.

16.

Teenage and Young Adult Cancer-Related Fatigue Is Prevalent, Distressing, and Neglected: It Is Time to Intervene. A Systematic Literature Review and Narrative Synthesis.

Spathis A, Booth S, Grove S, Hatcher H, Kuhn I, Barclay S.

J Adolesc Young Adult Oncol. 2015 Mar;4(1):3-17. doi: 10.1089/jayao.2014.0023. Review.

17.

Presentation and management of pulmonary artery sarcoma.

Wong HH, Gounaris I, McCormack A, Berman M, Davidson D, Horan G, Pepke-Zaba J, Jenkins D, Earl HM, Hatcher HM.

Clin Sarcoma Res. 2015 Jan 21;5(1):3. doi: 10.1186/s13569-014-0019-2. eCollection 2015.

18.

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.

Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Ray-Coquard I, Paul J, Blay JY, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Pauporté I, Welch JJ, Law K, Trimble T, Seymour M.

Eur J Cancer. 2015 Feb;51(3):271-81. doi: 10.1016/j.ejca.2014.10.027. Epub 2014 Dec 24. Review.

19.

Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer.

Ring A, Wheatley D, Hatcher H, Laing R, Plummer R, Uttenreuther-Fischer M, Temple G, Pelling K, Schnell D.

Clin Cancer Res. 2015 Jun 15;21(12):2737-44. doi: 10.1158/1078-0432.CCR-14-1812. Epub 2014 Nov 4.

20.

Trabectedin for advanced soft tissue sarcomas: a single institution experience.

Gounaris I, Hatcher HM, Davidson D, Sherbourne K, Alam S, Zaki KA, Horan G, Earl HM.

Future Oncol. 2014 Aug;10(11):1843-51. doi: 10.2217/fon.14.10. Epub 2014 Jan 22.

21.

IRP2 regulates breast tumor growth.

Wang W, Deng Z, Hatcher H, Miller LD, Di X, Tesfay L, Sui G, D'Agostino RB Jr, Torti FM, Torti SV.

Cancer Res. 2014 Jan 15;74(2):497-507. doi: 10.1158/0008-5472.CAN-13-1224. Epub 2013 Nov 27.

22.

Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature.

Wong HH, Hatcher HM, Benson C, Al-Muderis O, Horan G, Fisher C, Earl HM, Judson I.

Clin Sarcoma Res. 2013 Nov 26;3(1):14. doi: 10.1186/2045-3329-3-14.

23.

Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells.

Tesfay L, Huhn AJ, Hatcher H, Torti FM, Torti SV.

PLoS One. 2012;7(7):e40030. doi: 10.1371/journal.pone.0040030. Epub 2012 Jul 2.

24.

Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.

Wan M, Huang W, Kute TE, Miller LD, Zhang Q, Hatcher H, Wang J, Stovall DB, Russell GB, Cao PD, Deng Z, Wang W, Zhang Q, Lei M, Torti SV, Akman SA, Sui G.

Am J Pathol. 2012 May;180(5):2120-33. doi: 10.1016/j.ajpath.2012.01.037. Epub 2012 Mar 20.

25.

Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.

Ainsworth NL, Marshall A, Hatcher H, Whitehead L, Whitfield GA, Earl HM.

Ann Oncol. 2012 Jul;23(7):1845-53. doi: 10.1093/annonc/mdr539. Epub 2011 Nov 21.

PMID:
22104575
26.

Management of malignant ovarian germ cell tumors.

Parkinson CA, Hatcher HM, Ajithkumar TV.

Obstet Gynecol Surv. 2011 Aug;66(8):507-14. doi: 10.1097/OGX.0b013e318234ede9. Review.

PMID:
22018453
27.

Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy.

Ding X, Singh R, Burke A, Hatcher H, Olson J, Kraft RA, Schmid M, Carroll D, Bourland JD, Akman S, Torti FM, Torti SV.

Nanomedicine (Lond). 2011 Oct;6(8):1341-52. doi: 10.2217/nnm.11.37. Epub 2011 Apr 20.

28.

Multidisciplinary management of malignant ovarian germ cell tumours.

Parkinson CA, Hatcher HM, Earl HM, Ajithkumar TV.

Gynecol Oncol. 2011 Jun 1;121(3):625-36. doi: 10.1016/j.ygyno.2010.12.351. Epub 2011 Feb 25.

PMID:
21353692
29.

Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation.

Fisher JW, Sarkar S, Buchanan CF, Szot CS, Whitney J, Hatcher HC, Torti SV, Rylander CG, Rylander MN.

Cancer Res. 2010 Dec 1;70(23):9855-64. doi: 10.1158/0008-5472.CAN-10-0250. Epub 2010 Nov 23.

30.

Ferroportin and iron regulation in breast cancer progression and prognosis.

Pinnix ZK, Miller LD, Wang W, D'Agostino R Jr, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM.

Sci Transl Med. 2010 Aug 4;2(43):43ra56. doi: 10.1126/scisignal.3001127. Erratum in: Sci Transl Med. 2010 Aug 25;2(46):46er1.

31.

Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode.

Neal RE 2nd, Singh R, Hatcher HC, Kock ND, Torti SV, Davalos RV.

Breast Cancer Res Treat. 2010 Aug;123(1):295-301. doi: 10.1007/s10549-010-0803-5. Epub 2010 Feb 27.

32.

Synthetic and natural iron chelators: therapeutic potential and clinical use.

Hatcher HC, Singh RN, Torti FM, Torti SV.

Future Med Chem. 2009 Dec;1(9):1643-70. doi: 10.4155/fmc.09.121. Review.

33.

Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation.

Burke A, Ding X, Singh R, Kraft RA, Levi-Polyachenko N, Rylander MN, Szot C, Buchanan C, Whitney J, Fisher J, Hatcher HC, D'Agostino R Jr, Kock ND, Ajayan PM, Carroll DL, Akman S, Torti FM, Torti SV.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12897-902. doi: 10.1073/pnas.0905195106. Epub 2009 Jul 20.

34.

Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?

Biswas S, Burke A, Cherian S, Williams D, Nicholson J, Horan G, Jefferies S, Williams M, Earl HM, Burnet NG, Hatcher H.

Pediatr Blood Cancer. 2009 Jul;52(7):796-803. doi: 10.1002/pbc.21899.

PMID:
19202566
35.

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator.

Jiao Y, Wilkinson J 4th, Di X, Wang W, Hatcher H, Kock ND, D'Agostino R Jr, Knovich MA, Torti FM, Torti SV.

Blood. 2009 Jan 8;113(2):462-9. doi: 10.1182/blood-2008-05-155952. Epub 2008 Sep 24.

36.

Curcumin: from ancient medicine to current clinical trials.

Hatcher H, Planalp R, Cho J, Torti FM, Torti SV.

Cell Mol Life Sci. 2008 Jun;65(11):1631-52. doi: 10.1007/s00018-008-7452-4. Review.

37.

Management of solid tumours in organ-transplant recipients.

Ajithkumar TV, Parkinson CA, Butler A, Hatcher HM.

Lancet Oncol. 2007 Oct;8(10):921-32. Review.

PMID:
17913661
38.

Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib.

Murray M, Hatcher H, Jessop F, Williams D, Carroll N, Bulusu R, Judson I.

Pediatr Blood Cancer. 2008 Feb;50(2):386-8.

PMID:
17729245
39.

A review of the surgical management of metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate (Glivec).

Barnes G, Bulusu VR, Hardwick RH, Carroll N, Hatcher H, Earl HM, Save VE, Balan K, Jamieson NV.

Int J Surg. 2005;3(3):206-12. Epub 2005 Sep 12.

40.

Digoxin therapy for heart failure: an update.

Morris SA, Hatcher HF, Reddy DK.

Am Fam Physician. 2006 Aug 15;74(4):613-8.

41.

Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity.

Watson PM, Commins SP, Beiler RJ, Hatcher HC, Gettys TW.

Am J Physiol Endocrinol Metab. 2000 Aug;279(2):E356-65.

42.

Kallikrein-binding protein is induced by growth hormone in the dwarf rat.

Hatcher HC, Wright NM, Chao J, Chao L, Ma JX.

FASEB J. 1999 Oct;13(13):1839-44.

PMID:
10506588
43.

Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats.

Hatcher HC, Ma JX, Chao J, Chao L, Ottlecz A.

Invest Ophthalmol Vis Sci. 1997 Mar;38(3):658-64.

PMID:
9071220
44.

Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.

Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J.

Exp Eye Res. 1996 Jul;63(1):19-26.

PMID:
8983960
45.

Long-term treatment of osteopetrosis with recombinant human interferon gamma.

Key LL Jr, Rodriguiz RM, Willi SM, Wright NM, Hatcher HC, Eyre DR, Cure JK, Griffin PP, Ries WL.

N Engl J Med. 1995 Jun 15;332(24):1594-9.

46.

Recombinant human interferon gamma therapy for osteopetrosis.

Key LL Jr, Ries WL, Rodriguiz RM, Hatcher HC.

J Pediatr. 1992 Jul;121(1):119-24.

PMID:
1320672
47.

Enzymatic control of biological deposits in papermaking.

Hatcher HJ.

Biotechnol Adv. 1984;2(2):309-17.

PMID:
14545701
49.

Osteomyelitis of the patella. Gentamicin therapy associated with encephalopathy.

Wadlington WB, Hatcher H, Turner DJ.

Clin Pediatr (Phila). 1971 Oct;10(10):577-80. No abstract available.

PMID:
5002153
50.

Nitrification of aspartate by Aspergillus flavus.

Hatcher HJ, Schmidt EL.

Appl Microbiol. 1971 Feb;21(2):181-6.

Supplemental Content

Loading ...
Support Center